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Abstract: Background: When breastfeeding is impossible or insufficient, the use of cow’s milk-based
hypoallergenic infant formulas is an option for infants suffering from or at risk of developing cow’s
milk allergy. As the Camelidae family has a large evolutionary distance to the Bovidae family and as
camel milk differs from cow’s milk protein composition, there is a growing interest in investigating
the suitability of camel milk as an alternative to cow’s milk-based hypoallergenic infant formulas.
Methods: The aim of the study was to compare the allergenicity and immunogenicity of camel and
cow’s milk as well as investigating their cross-reactivity using a Brown Norway rat model. Rats were
immunised intraperitoneally with one of four products: camel milk, cow’s milk, cow’s milk casein or
cow’s milk whey fraction. Immunogenicity, sensitising capacity, antibody avidity and cross-reactivity
were evaluated by means of different ELISAs. The eliciting capacity was evaluated by an ear swelling
test. Results: Camel and cow’s milk showed similarity in their inherent immunogenicity, sensitising
and eliciting capacity. Results show that there was a lower cross-reactivity between caseins than
between whey proteins from camel and cow’s milk. Conclusions: The study showed that camel and
cow’s milk have a low cross-reactivity, indicating a low protein similarity. Results demonstrate that
camel milk could be a promising alternative to cow’s milk-based hypoallergenic infant formulas.
Keywords: food allergy; cow’s milk; camel milk; infant formula; animal models
1. Introduction
Cow’s milk allergy (CMA) is the most prevalent food allergy in infants and small children [1],
affecting around 2.5% [2,3], although differences are observed between studies and countries [4].
Although most CMA children outgrow their allergy, some keep it for life [5]. Originally, it was though
that most children did outgrow their CMA before the age of three years, but there seems to be a
tendency that more and more children outgrow their CMA later in life and for some it may even
last for lifetime [6,7]. Breastfeeding is the most suited source of nutrition for a newborn infant [8].
However, in some situations, breastfeeding is impossible or insufficient and a substitute such as an
infant formula is needed [9]. Infant formulas are usually based on cow’s milk, as this is the most
easily accessible milk source globally [10]. When an infant suffers from or is at risk of developing
CMA, alternatives to conventional infant formulas are recommended such as hypoallergenic infant
formulas, based on extensively or partially hydrolysed cow’s milk proteins [11]. In addition to cow’s
milk-based hypoallergenic infant formulas, additional alternatives to conventional infant formulas
are found on the market, such as amino acid-based infant formulas, plant-based infant formulas
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(e.g., soya-based) and infant formulas based on other mammalian milk (e.g., goat or sheep) [8,12,13].
Extensively and partially hydrolysed infant formulas as well as amino acid-based infant formulas
are poor in flavour, and, thus, some newborns may refuse them [5,14]. On the other hand, it has
been reported that sheep and goat milk-based infant formulas may only be an alternative for some
newborns due to a high cross-reactivity between cow’s milk proteins and proteins from goat and
sheep milk [13,15]. In addition, plant-based infant formulas are seldom recommended due to their
low nutritional value [16,17]. For those reasons, new or improved alternatives to conventional infant
formulas are still of interest.
Due to the large evolutionary distance between Camelus dromedaries (Camelidae family) and
the Bovidae family animals, camel milk is quite different in its composition compared to cow’s milk.
Equivalent to human milk, the allergenic milk protein β-lactoglobulin (BLG) is also absent in camel
milk [18]. Moreover, similar to human milk, camel milk has approximately double the amount
of β-casein and approximately five times the amount of immunoglobulins in comparison to cow’s
milk [19]. Rastani et al. [13] showed that CMA patients did not recognise camel milk by immunoblotting
and concluded that camel milk is a promising alternative to cow’s milk for infant formula manufacture.
Further, based on double-blind, placebo-controlled food challenges, Navarre-Rodriguez et al. [20]
concluded that camel milk is a safe and tolerable alternative for CMA patients above the age of one
year. Camel milk is already commercially available in the Middle East, Australia, United Kingdom
and the Netherlands [21–24]. In other regions such as in African countries, it is a traditionally
consumed product, although without a control on its quality and safety [25]. There are a number of
studies showing that camel milk is nutritionally suitable for human consumption [21,26]. For those
reasons, camel milk is an exciting and suitable product with the potential to be a future alternative to
hypoallergenic cow’s milk-based infant formulas in prevention, treatment and management of CMA
in infants and small children.
The purpose of this study was to investigate the immunogenicity and allergenicity of camel and
cow’s milk as well as studying cross-reactivity between proteins from the two sources. To do this,
Brown Norway (BN) rats were immunised intraperitoneally (i.p.) with either camel milk, cow’s milk,
cow’s milk casein fraction or cow’s milk whey fraction and antibody responses were evaluated
for level, specificity, avidity, functionality and cross-reactivity by means of different enzyme-linked
immunosorbent assays (ELISAs), immunoblotting and in vivo test. This should allow for an overview
of the usability of camel milk as an alternative to hypoallergenic infant formulas.
2. Materials and Methods
2.1. Products
Powders of cow’s milk, cow’s milk casein fraction and cow’s milk whey fraction were kindly
provided by Arla Foods Ingredients Videbæk, Denmark. Powder of camel milk was kindly provided
by Dairy Farm Smits, Berlicum, the Netherlands. Products were tested by Pierce™ LAL Chromogenic
Endotoxin Quantitation Kit (88282, Thermo Fisher, Waltham, MA, USA) in accordance with the
instruction given by the manufacturer. Whereas camel milk, cow’s milk and cow’s milk whey fraction
had an endotoxin level <2 endotoxin units (EU) per mg of protein, cow’s milk casein fraction had an
endotoxin level of approximately 66 EU per mg of protein.
2.2. In Silico Protein Analyses
CLC Main Workbench 8.0 (Redwood City, CA, USA) was used to compare selected protein amino
acid sequences from cow’s milk with those of goat, sheep, camel and human milk. Protein sequences
were downloaded from UniProt (http://www.uniprot.org).
Nutrients 2018, 10, 1903 3 of 18
2.3. Denaturation of Products
Camel milk and cow’s milk were denatured to obtain unfolded structures of proteins.
Denaturation was performed by reduction and alkylation, as previously described by Madsen et al. [27].
2.4. SDS-PAGE Electrophoresis
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) with camel milk,
denatured camel milk, cow’s milk, denatured cow’s milk, cow’s milk casein fraction and cow’s milk
whey fraction was performed using 5 µg of each product dissolved in Laemmli buffer (65.8 mM
Tris-HCl, pH 6.8, 26.3% (w/v) glycerol and 2.1% (w/v) SDS, 161-0737, Bio-Rad, Hercules, CA, USA)
with addition of β-mercaptoethanol (14.2 M, 161-0710, Bio-Rad). Samples were incubated for 5 min at
95 ◦C and afterwards loaded onto a 4–20% gel (Mini-Protean TGX Stain-Free gel, 456-8093, Bio-Rad).
SDS-PAGE was performed in running buffer (25 mM Tris and 192 mM Glycine and with addition of
0.1% (w/v) SDS, pH 8.3, 161-0732, Bio-Rad). Additionally, 10 µL of the molecular weight Precision
Plus Protein™ Unstained Standard (161-0363, Bio-Rad) was loaded onto the gel. Gel electrophoresis
was run at 200 V with constant current at room temperature (RT). Afterwards, the gel was stained with
Bio Safe™ Coomassie (161-0786, Bio-Rad) for 1 h at RT and photographed using Imager ChemiDoc
XRS+ (Bio-Rad).
2.5. Animals
BN rats were from the in-house breeding colony, at the National Food Institute, Technical University
of Denmark, Denmark, and kept in macrolon cages at 22 ◦C ± 1 ◦C with 55 ± 5% relative humidity at a
12-h light–dark cycle. Air exchange was applied 8–10 times per hour with overpressure. BN rats were
inspected twice a day and weighted once per week. Rats were kept on a diet free from milk and soy
allergens for ≥10 generations. Feed containing rice flour and fish was given ad libitum as well as was
acidified tap water.
2.6. Animal Sensitisation Studies
To sensitise animals and raise antibodies against camel milk, cow’s milk, cow’s milk casein fraction
or cow’s milk whey fraction, BN rats 4–7 weeks of age, were divided into five groups of eight rats
(n = four/gender), and housed two per cage. Groups of rats were immunised i.p. three times with 200
µg of product dissolved in phosphate buffer saline (PBS) (137 mM NaCl, 3 mM KCl, 8 mM Na2HPO4,
1 mM KH2PO4, pH 7.2) without the use of adjuvant one time at Day 0, 14 and 28 (Figure 1). One group
of rats was not immunised to act as a control group (naïve animals) for an ear swelling test. At Day
35, rats were sacrificed and blood collected. The animal experiment was carried out at the National
Food Institute, Technical University of Denmark under ethical approval given by the Danish Animal
Experiments Inspectorate and the authorisation number 2015-15-0201-00553-C1. The experiment was
overseen by the National Food Institute’s in-house Animal Welfare Committee for animal care and use.
2.7. Ear Swelling Test
To investigate the eliciting capacity of camel and cow’s milk, at Day 33 of the experiment, an
ear swelling test was performed. Rats were anesthetised with hypnorm-dormicum and baseline ear
thickness was measured. Subsequently, 20 µL of PBS with 10 µg of camel milk or 10 µg of cow’s milk
were injected into the right or left ear, respectively, and ear thicknesses were measured again one hour
after injections. Naïve rats were included to see unspecific ear swelling and irritation capacity after
camel and cow’s milk protein ear injection. Delta ear swelling was calculated.
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Figure 1. Animal experimental design. Brown Norway rats were immunised i.p. with 200 µg of camel
milk, cow’s milk, cow’s milk casein fraction or cow’s milk whey fraction three times, at Days 0, 14 and
28. At Day 33 an ear swelling test was performed and at Day 35 rats were sacrificed and blood collected.
Pictures were purchased from https://www.colourbox.com.
2.8. Indirect ELISA for Specific IgG1 Detection
To detect IgG1 antibodies specific for camel milk, denatured camel milk, cow’s milk and denatured
cow’s milk, indirect ELISAs were performed using Maxisorp microtitre plates (96-well, Nunc, Roskilde,
Denmark). Plates were coated with 100 µL/well of 10 µg/mL of camel milk, denatured camel milk,
cow’s milk or denatured cow’s milk, in coating buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6),
and incubated overnight at 4 ◦C. Between each step, plates were washed five times in PBS with 0.01%
(w/v) Tween 20 (PBS-T). For all steps that required incubation, plates were incubated for one hour
in the dark at RT, with gentle agitation. First, plates were incubated with 50 µL/well of two-fold
serial dilution of serum samples (v/v) in PBS-T. In each plate, positive and negative control serum
samples were included in order to identify potential plate-to-plate variance. For antibody detection,
50 µL/well of secondary antibody (horse radish peroxidase (HRP)-labelled-mouse-anti-rat IgG1,
3060-05, Southern Biotech, Birmingham, AL, USA) diluted 1:20,000 (v/v) in PBS-T was added to the
plates. After incubation plates were additionally washed twice with tap water. To visualise specific
antibody detection, 100 µL/well of TMB-one (3,3′,5,5′-tetramethylobenzidine, 4380A, Kementec
Diagnosis, Taastrup, Denmark) was added and incubated for 12 min at RT. The reaction was stopped
with 100 µL/well 0.2 M H2SO4 and the absorbance was measured at 450 nm with a reference
wavelength of 630 nm using a microtitre reader (Gen5, BioTek, EL800 Instrument, Winooski, VT, USA).
The cut-off values were set to be higher than the mean absorbance of negative control plus three times
the standard deviation (SD). Results were expressed in log2 titre values with a cut-off at the optical
density (OD) of 0.1 for IgG1 specific for camel milk, cow’s milk and denatured cow’s milk and 0.15 for
IgG1 specific for denatured camel milk.
2.9. Antibody Capture ELISA to Detect Specific IgE
To detect IgE specific for camel milk, denatured camel milk, cow’s milk and denatured cow’s
milk, antibody capture ELISAs were performed using Maxisorp microtitre plates (96-well, Nunc)
coated with 100 µL/well of mouse anti-rat IgE (HDMAB-123, Hydri-Domus, Nottingham, UK) diluted
1:2000 in coating buffer and incubated overnight at 4 ◦C. Between each step, plates were washed
five times with PBS-T. For all steps that required incubation, plates were incubated for one hour
in the dark at RT, with gentle agitation. For camel and cow’s milk specific IgE detection, antibody
capture ELISA was optimised to use proper blocking for each product. Plates were blocked at 37 ◦C,
200 µL/well, with 3% (v/v) horse serum for camel milk specific IgE detection and 5% (v/v) rabbit
serum for cow’s milk specific IgE detection, diluted in PBS-T. Subsequently, plates were incubated for
one hour with 50 µL/well of two-fold serial dilution of serum samples (v/v) in PBS-T. In each plate,
positive and negative control serum samples were included. Afterwards, 50 µL/well of 0.05 µg/mL of
10:1 digoxigenin (DIG)-coupled camel milk or 0.1 µg/mL of 10:1 DIG-coupled cow’s milk in PBS-T
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were added, to detect specific IgE. Next, plates were incubated with 100 µL/well of HRP-labelled
sheep-anti-DIG-POD (11633716001, Roche, Diagnostics GmbH, Mannheim, Germany) diluted 1:1000
(v/v) in PBS-T. After this step, plates were additionally washed twice with tap water and incubated
for 12 min with 100 µL/well of TMB-one (Kementec Diagnosis). The reaction was stopped with
100 µL/well of 0.2 M H2SO4 and the absorbance was measured. Results were expressed as log2 titre
value with an individual cut-off of plates at an OD of 0.145–0.2 for IgE specific for camel milk and of
0.125–0.175 for IgE specific for cow’s milk.
2.10. Avidity Measurements
To measure binding strength between antigens and IgG1 antibodies from serum samples,
avidity ELISA was performed as previously described by Bøgh et al. [28]. Serum samples from
rats that reached an OD of at least 0.5 were included.
2.11. Inhibitory ELISA
To examine the cross-reactivity between proteins from camel and cow’s milk, inhibitory ELISA
was performed. The procedure was as described for the indirect IgG1 ELISA with few exceptions.
Serum samples for each group of animals were pooled and diluted in PBS-T to reach an OD of
approximately 2.0. Serum pools were then pre-incubated for one hour with ten-fold serial dilutions
of camel and cow’s milk. After pre-incubation, samples were added to the plates in duplicates and
incubated for one hour. The assay was performed twice. The results were expressed in percentage
inhibition against the concentration of the inhibitor.
2.12. Immunoblotting
To do immunoblotting, SDS-PAGE was performed with 5 µg of camel and cow’s milk as described
previously. In addition, SDS-PAGE with an eight-time higher load of proteins (40 µg) was performed
to visualise cross-reactivity. After SDS-PAGE, proteins were transferred onto polyvinylidene difluoride
membranes (Trans-Blot® Turbo™ Mini PVDF Transfer Pack, 1704156, Bio-Rad) by semidry blotting
(Trans-Blot® Turbo™ Transfer System, 170-4150, Bio-Rad) at constant 200 V. Membranes were washed
three times for 5 min in PBS-T (0.05% v/v Tween 20) and each blocked with 20 mL of 5% ovalbumin
(OVA, egg whites from chicken, Sigma Aldrich, St. Louis, MO, USA) diluted in PBS-T (0.1% v/v
Tween 20) and incubated for one hour in the dark at RT, on a shaking table. The 5% OVA solution was
used during the whole experiment as a blocking solution. After blocking, membrane was divided
into two pieces, both pieces with 5 µg of camel and cow’s milk. Next, 10 mL of serum pooled from
rats immunised with cow’s milk diluted 1:3000 (v/v) in blocking solution or serum pooled from rats
immunised with camel milk diluted 1:8000 (v/v) in blocking solution were added separately to each half
of the membrane containing 5 µg of camel and cow’s milk and incubated for one hour in the dark at RT,
on a shaking table. Half of the membrane with 40 µg of cow’s milk was incubated with serum pooled
from rats immunised with camel milk diluted 1:500 (v/v) in blocking solution, while the other half of
the membrane with 40 µg of camel milk was incubated with serum pooled from rats immunised with
cow’s milk diluted 1:500 (v/v) in blocking solution. Afterwards, membranes were washed three times
for 5 min in PBS-T (0.05% v/v Tween 20) and 10 mL of the secondary antibody diluted 1:15,000 together
with StrepTacin-HRP conjugate (Bio-Rad) for Precision Plus Protein™ Unstained Standard detection,
diluted 1:15,000 in blocking solution were added to each half of the membrane. Membranes were
incubated for one hour in the dark at RT, on a shaking table. Subsequently, membranes were washed
three times for 5 min in PBS-T (0.05% v/v Tween 20) followed by PBS washing two times for 5 min
to remove the detergent. Membranes were incubated with peroxidase substrate (Clarity™ Western
ECL Substrate, 1705060, Bio-Rad) for 5 min. After incubation, membranes were developed and
photographed using Imager ChemiDoc XRS+ (Bio-Rad).
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2.13. Statistical Analysis of Data
Graphs and statistical analyses of the data were performed using GraphPrism version 7.0
(San Diego, CA, USA). Results from indirect and antibody-capture ELISAs were expressed as log2
antibody titre values.
ELISA results expressed as log2 antibody titres were tested for normality distribution. Based on
the results, either parametric or non-parametric t-tests were performed. Differences were regarded as
statistically significant when p ≤ 0.05. Asterisks indicate statistically significant differences between
two given groups: ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗ ∗ ∗ = p ≤ 0.001, ∗ ∗ ∗∗ p ≤ 0.0001.
Inhibition curves resulting from avidity and inhibitory ELISA were examined with one-way
repeated-measurements ANOVA test. Analyses showed no statistically significant differences between
curves, thus IC50 calculations were performed. IC50 was calculated using sigmoidal dose response
with non-linear regression.
3. Results
3.1. Protein Characterisation
The primary sequence from selected cow’s milk proteins were aligned to their counterpart proteins
in milk from goat, sheep, camel and human to investigate the amino acid sequence identity between
the different species and to predict the potential cross-reactivity between proteins of interest. As shown
in Table 1, goat and sheep milk protein sequences show a very high percentage identity to cow’s
milk proteins, ranging from a protein sequence identity of 85–95% for goat and sheep. A much lower
protein sequence identity was evidenced between camel and cow’s milk proteins, where the protein
identity ranged from 47% to 81%. This is very similar to the protein sequence identity of human and
cow’s milk proteins ranging from 33% to 76% and human and camel milk proteins ranking from 40%
to 76%. In addition, neither camel nor human milk contains BLG [18]. Similarities between camel and
cow’s milk caseins sequences were shown to be slightly lower than between the whey proteins.
Table 1. Amino acid sequence identity between cow’s and goat, sheep, camel and human milk proteins.
Goat Sheep Camel Human (c)
Casein
β-casein 91 91 67 55 (60)
αs1-casein 88 88 47 33 (40)
αs2-casein 88 89 56 NA (a)
κ-casein 85 85 58 52 (60)
Whey
α-lactalbumin 95 95 60 74 (62)
β-lactoglobulin 93 93 NA (b) NA (b)
serum albumin 88 92 81 76 (76)
lactoferrin 92 92 75 70 (74)
Sequence identity (%) between selected cow’s milk proteins and their counterpart milk proteins from goat, sheep,
camel and human expressed in percentage. Sequence alignments were performed using CLC Main Workbench
8.0 and UniProt and NCBI database. NA: not available. (a) αs2-casein not identified in human milk [29,30].
(b) β-lactoglobulin not available in camel and cow’s milk [18]. (c) Numbers in brackets represents sequence
identity between human and camel milk. Accession number: β-casein: Cow: AAA30431; Goat: AAA30906;
Sheep: CAA56139; Camel: CDO50354; Human: AAC82978. αs1-casein: Cow: AAA30429; Goat: CAA51022;
Sheep: AEN84772; Camel: O97943; Human: CAA55185. αs2-casein: Cow: NP_776953; Goat: CAC21704; Sheep:
CAA26983; Camel: O97944. κ-casein: Cow: CAA33034; Goat: CAA43174; Sheep: NP_001009378; Camel: CCI79378;
Human: CAA47048. α-lactalbumin: Cow: CAA29664; Goat: CAA28797; Sheep: CAA29665; Camel: P00710;
Human: AAA60345. β-lactoglobulin: Cow: CAA32835; Goat: CAA79623; Sheep: CAA31305. serum albumin: Cow:
CAA41735; Goat: XP_005681801; Sheep: CAA34903; Camel: XP_010981066; Human: AAN17825; lactoferrin: Cow:
AAA30610; Goat: AAA97958; Sheep: ACT76166; Camel: CAB53387; Human AAA59511.
SDS-PAGE electrophoresis was performed to display the protein profile of the products used in
this study. Caseins run as thick bands between 25 and 37 kilodalton (kDa) in both camel and cow’s
milk (Lanes 1–4, Figure 2) as well as in the casein fraction of cow’s milk (Lane 5) [31]. The band
corresponding to a molecular weight (MW) of around 30 kDa represents β-casein while the band
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immediately above represents α-caseins with a MW of around 35 kDa [19,31]. In cow’s milk as well
as in the whey fraction of cow’s milk (Lanes 3 and 6), a clear band representing BLG is evident
(~18 kDa) [1], which is not present in camel milk. In all lanes except for the lane corresponding to
the casein fraction of cow’s milk (Lane 6), the lower band represents α-lactalbumin (ALA) (~14 kDa),
while the two upper bands most likely represent lactoferrin (LF) (~75 kDa) and serum albumin (SA)
(~66 kDa) [19]. Immunoglobulins (~150 kDa) are only hardly seen due to their low amount in the
milk products. LF and SA are slightly more visible in the denatured version of the milk products
(Lanes 2 and 4) than their native counterparts. Another difference between the native and denatured
version of the milk products are a lower mobility of proteins in the denatured versions compared to
the native versions.
Nutrients 2018, 10, x FOR PEER REVIEW  7 of 18 
 
kDa) [1], which is not present in camel ilk. In all lanes except for the lane corresponding to the 
casein fraction f c w’s milk (Lane 6), the lower band represents α-lactalbumin (ALA) (~14 k a), 
          75 a) a  ser  al in (S ) 
66 kDa) [19]. Im unoglobulins (~150 kDa) re only hardly seen due to their low amount in the milk 
products. LF and SA are slightly more visibl  in the denatured version of the milk products (Lanes 2 
and 4) th  their native counterparts. Another difference between the native and den tured version 
of the milk products are a lowe  mobility of proteins in the denatured versions compared t  the native 
versions.  
 
Figure 2. SDS-PAGE electrophoresis. Gel electrophoresis, with native and denatured camel and cow’s 
milk as well as with native cow’s milk casein fraction and native cow’s milk whey fraction, was 
performed to display protein profiles. M, protein standard (kDa); 1, camel milk; 2, denatured camel 
milk; 3, cow’s milk; 4, denatured cow’s milk; 5, cow’s milk casein fraction; 6, cow’s milk whey fraction. 
BLG, β-lactoglobulin; ALA, α-lactalbumin. 
3.2. Camel and Cow’s Milk Immunogenicity and Cross-Reactivity 
Serum samples from individual BN rats immunised with camel milk, cow’s milk, cow’s milk 
casein fraction or cow’s milk whey fraction were assessed for specific IgG1 by means of indirect 
ELISAs. Figure 3A shows the IgG1 responses against both the native and denatured version of camel 
as well as cow’s milk proteins. 
The immunogenicity of camel and cow’s milk appears to be very similar as there is no 
statistically significant difference between the level of camel milk specific IgG1 raised against camel 
milk and the level of cow’s milk specific IgG1 raised against cow’s milk (Figure 3A). For both 
antibodies raised against camel or cow’s milk proteins, there is a statistically significant difference 
between the IgG1 reactivity towards camel milk and cow’s milk proteins, indicating a low cross-
reactivity between camel and cow’s milk proteins. For antibodies raised against camel milk, the IgG1 
reactivity against cow’s milk proteins was ~30 fold lower than the reactivity against camel milk 
proteins, measured by the amount of specific antibodies. Opposite the IgG1 reactivity against camel 
milk proteins was ~50-fold lower than the reactivity against cow’s milk proteins for sera raised 
against cow’s milk proteins. This was shown irrespectively of responses that were measured against 
the native or denatured version of the milk proteins. 
The IgG1 responses in rats immunised with either the casein or the whey fraction of cow’s milk, 
are shown in Figure 3B. For both groups of animals, the IgG1 responses against native and denatured 
camel milk were statistically significantly lower than the responses against native and denatured 
cow’s milk, stressing a low cross-reactivity for both the casein and the whey fraction of camel and 
cow’s milk proteins. For antibodies raised against casein, the IgG1 reactivity against native camel 
milk proteins was ~250-fold lower than the reactivity against cow’s milk proteins, while for 
antibodies raised against whey, the IgG1 reactivity against camel milk proteins was ~15-fold lower 
i 2. SDS-PAGE lectrophoresis. Gel electr phoresis, with native and denatured camel and
cow’s milk as well as with native cow’s milk casein fraction nd native cow’s milk whey fraction,
was performe to dis lay protein profiles. M, protein standard (kD ); 1, camel milk; 2, d natured
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3.2. Camel and Cow’s Milk Immunogenicity and Cross-Reactivity
Serum samples from individual BN rats immunised with camel milk, cow’s milk, cow’s milk
casein fraction or cow’s milk whey fraction were assessed for specific IgG1 by means of indirect ELISAs.
Figure 3A shows the IgG1 responses against both the native and denatured version of camel as well as
cow’s milk proteins.
The immunogenicity of camel and cow’s milk appears to be very similar as there is no statistically
significant difference between the level of camel milk specific IgG1 raised against camel milk and the
level of cow’s milk specific IgG1 raised against cow’s milk (Figure 3A). For both antibodies raised
against camel or cow’s milk proteins, there is a statistically significant difference between the IgG1
reactivity towards camel milk and cow’s milk proteins, indicating a low cross-reactivity between camel
and cow’s milk proteins. For antibodies raised against camel milk, the IgG1 reactivity against cow’s
milk proteins was ~30 fold lower than the reactivity against camel milk proteins, measured by the
amount of specific antibodies. Opposite the IgG1 reactivity against camel milk proteins was ~50-fold
lower than the reactivity against cow’s milk proteins for sera raised against cow’s milk proteins.
This was shown irrespectively of responses that were measured against the native or denatured
version of the milk proteins.
The IgG1 responses in rats immunised with either the casein or the whey fraction of cow’s milk,
are shown in Figure 3B. For both groups of animals, the IgG1 responses against native and denatured
camel milk were statistically significantly lower than the responses against native and denatured cow’s
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milk, stressing a low cross-reactivity for both the casein and the whey fraction of camel and cow’s milk
proteins. For antibodies raised against casein, the IgG1 reactivity against native camel milk proteins
was ~250-fold lower than the reactivity against cow’s milk proteins, while for antibodies raised against
whey, the IgG1 reactivity against camel milk proteins was ~15-fold lower than the reactivity against
cow’s milk proteins. This indicates a lower cross-reactivity between camel and cow’s milk caseins than
whey proteins.
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Figure 3. Specific IgG1 antibody responses. Comparison of specific IgG1 antibody responses toward
cow’s milk ( ), camel milk (N), denatured cow’s milk (#) ca el milk (∆) raised in
rats i munised with camel milk, cow’s milk, cow’s milk casein fracti n or cow’s milk whey fraction.
Each symbol represents the spe ific IgG1 titre value for an ind vidual rat. (A) Comparison of native
an denatured camel milk and cow’s milk spe ific IgG1 antibody responses in rats immunised with
camel r cow’s milk, respectively. Horizontal lines display the edian l f r each group of rats.
Statistically significant difference between two groups was determined using the no -parametric
Mann–Whitney test. Asterisk indicate statistically significant differ nces between the two given
groups when: ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗ ∗ ∗ = p ≤ 0.001, ∗ ∗ p ≤ 0. 001. (B) Comparison of native
and denatured camel milk and cow’s milk specific IgG1 antibody responses in rats im unised with
cow’s milk casein or whey fraction. orizo tal li es is lay the median values for each group of
rats. Statistically significant difference between t o groups as determined using the non-parametric
Mann–Whitney test. Asterisks indicate statistically significant differences between the two given
groups when: ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗ ∗ ∗ = p 0.001, ∗ ∗ ∗∗ p ≤ 0.0001. (C) Comparison of
IgG1 antibody reactivity against native vs. denatured camel and cow’s milk. Horizontal lines display
the mean values for each group of rats. Statistically significant difference between two groups was
determined using the parametric t-test. Asterisks indicate statistically significant differences between
the two given groups when: ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗ ∗ ∗ = p ≤ 0.001, ∗ ∗ ∗∗ p ≤ 0.0001.
3.3. Linear and Conformational Epitope Recognition
The study showed that there were no statistically significant differences between the IgG1
responses against the native and denatured versions of milk proteins for rats immunised with neither
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camel milk nor cow’s milk, indicating that linear epitopes are dominating both responses (Figure 3C).
In addition, the IgG1 raised against cow’s milk caseins showed no statistically significant difference
in their reactivity against the native or denatured version of milk proteins with an approximate
ratio of 1:1. In contrast, although IgG1 raised against cow’s milk whey showed no statistically
significant difference in their reactivity against the native and denatured version of milk proteins,
the ratio between IgG1 specific for native vs. denatured cow’s milk was 4:1. This demonstrates that,
while caseins primarily induce antibodies against linear epitopes, whey primarily induces antibodies
against conformational epitopes.
3.4. Inhibitory ELISA
Inhibitory ELISA was performed with sera pools from groups of rats immunised with camel milk,
cow’s milk, cow’s milk casein or whey fraction in order to evaluate the competitive capacity of native
as well as denatured camel and cow’s milk.
3.4.1. IgG1 Antibody Competition of Native Camel and Cow’s Milk
While native camel milk was able to fully inhibit antibodies raised against camel milk, native
cow’s milk was only able to inhibit ~50% of the antibodies raised against camel milk (Figure 4A).
On the other hand, while native cow’s milk was fully capable of inhibiting the antibodies raised against
cow’s milk, native camel milk was only capable of inhibiting ~35% of antibodies raised against cow’s
milk (Figure 4B). While native cow’s milk was able to fully inhibit antibodies raised against both
the casein and the whey fraction of cow’s milk, native camel milk was only able to inhibit ~30% of
antibodies raised against cow’s milk casein (Figure 4C) and ~45% of antibodies raised against cow’s
milk whey (Figure 4D). This confirms previous results, showing a lower cross-reactivity between
casein compared to the whey fraction of camel and cow’s milk.
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Each symbol represents the percent inhibition of IgG1 specific antibodies at different inhibitor
concentrations. Error bars in the inhibition curves represent ± standard deviation (SD). (A) Inhibition
curve for sera raised against camel milk. (B) Inhibition curve for sera raised against cow’s milk.
(C) Inhibition curve for sera raised against cow’s milk casein fraction. (D) Inhibition curve for sera
raised against cow’s milk whey fraction. (E) Inhibition curve for sera raised against linear epitopes of
camel milk. (F) Inhibition curve for sera raised against linear epitopes of cow’s milk. (G) Inhibition
curve for sera raised against linear epitopes of cow’s milk casein fraction. (H) Inhibition curve for sera
raised against linear epitopes of cow’s milk whey fraction.
3.4.2. IgG1 Antibody Competition Towards Denatured Camel and Cow’s Milk
By performing inhibitory ELISA with the use of denatured versions of camel and cow’s milk,
we could only study the cross-reactivity as a measure of antibodies raised against linear epitopes.
While denatured camel milk was able to inhibit fully antibodies raised against linear epitopes of camel
milk, denatured cow’s milk was able to inhibit ~70% of the antibodies raised against linear epitopes of
camel milk (Figure 4E). On the other hand, while denatured cow’s milk was fully capable of inhibiting
the antibodies raised against linear epitopes of cow’s milk, denatured camel milk was only capable of
inhibiting ~35% of antibodies raised against cow’s milk (Figure 4F). While denatured cow’s milk was
able to fully inhibit antibodies raised against both linear epitopes of the casein and the whey fraction
of cow’s milk, denatured camel milk was only able to inhibit ~35% of antibodies raised against linear
epitopes of cow’s milk casein (Figure 4G) and ~45% of antibodies raised against linear epitopes of
cow’s milk whey (Figure 4H). This indicated a slightly higher cross-reactivity between linear epitopes
compared to conformational epitopes of camel and cow’s milk.
3.5. Specific IgG1 Antibody Avidity
Avidity ELISAs were performed to evaluate binding strength between specific IgG1 antibodies
and the milk proteins. Figure 5 displays the amount of potassium thiocyanate (KSCN) needed to inhibit
50% of the antibody–antigen binding. Results indicated that there were no statistically significant
differences in binding strength between IgG1 raised against camel milk and camel milk or cow’s milk.
Similar results were shown for IgG1 raised against cow’s milk and their binding strength towards
cow’s milk and camel milk, although slightly higher avidity was shown between antibodies raised
against cow’s milk and cow’s milk compared to the avidity between antibodies raised against cow’s
milk and camel milk.
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as potassium thiocyanate concentration needed to inhibit 50% of the IgG1 response towards camel
or cow’s milk for groups of rats immunised with camel milk or cow’s milk. Horizontal lines
display the median values for each group of rats. Statistically significant difference between two
groups was determined using the non-parametric Mann–Whitney test. Asterisks indicate statistically
significant differences between two given groups when: ∗ = p ≤ 0.05, ∗∗ = p ≤ 0.01, ∗ ∗ ∗ = p ≤ 0.001,
∗ ∗ ∗∗ p ≤ 0.0001.
3.6. Sensitising Capacity of Camel and Cow’s Milk
As IgE is the main player in food allergies [32], specific IgE titres were determined by the use of
antibody-capture ELISAs. The results showed no obvious differences in the sensitising capacity of
camel and cow’s milk proteins, both products containing the capacity to induce high levels of specific
IgE antibodies (Figure 6). No statistical analysis could be performed as the camel and cow’s milk
assays cannot be directly compared because of their potential different sensitivity. In line with the
specific IgG1 responses, also for the specific IgE responses a low cross-reactivity between camel and
cow’s milk proteins was identified. Furthermore, in accordance with the IgG1 results, also for the IgE
results a lower cross-reactivity could be observed for the casein fraction compared to the whey fraction
of camel and cow’s milk proteins.
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Figure 6. Specific IgE antibody responses. Comparison of specific IgE responses towards cow’s ( ) and
camel milk (N) in rats immunised with camel milk, cow’s milk, cow’s milk casein fraction or cow’s
milk whey fraction. Each symbol represents a specific IgE titre value for an individual rat. Horizontal
lines on the graph display the median values for each group of rats.
3.7. Eliciting Capacity of Camel and Cow’s Milk
The ability of camel and cow’s milk to elicit allergic reactions was determined by an ear swelling
test (Figure 7). Rats sensitised to camel milk showed a larger reaction towards camel milk than towards
cow’s milk, and opposite rats sensitised to cow’s milk showed a larger reaction against cow’s milk than
camel milk, which correlates very well with the specific IgE responses (Figure 6), and confirms the low
cross-reactivity between camel and cow’s milk proteins. While a statistically significant difference was
obtained for rats sensitised with camel milk, no statistically significant difference was obtained for rats
sensitised with cow’s milk. This may be explained by the fact that only seven animals are included in
the cow’s milk sensitised group compared to eight animals in the camel milk sensitised group, as one
cow’s milk sensitised animal died during the ear swelling test due to anaphylaxis. This has biased
the results as this animal would probably be the one that would have responded with the greatest ear
swelling. The groups immunised with cow’s milk casein fraction or cow’s milk whey fraction both
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showed a significantly larger response towards cow’s milk compared to camel milk; however, in line
with the antibody responses, the casein proteins were shown to have a lower cross-reactivity than the
whey proteins.Nutrients 2018, 10, x FOR PEER REVIEW  12 of 18 
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3.8. Immunoblot
Immunoblotting was performed to investigate the specificity of the responses towards camel and
cow’s milk. Figure 8A shows the specificity of antibodies raised against cow’s milk. BLG (~18 kDa)
and the two casein fractions between 25 and 37 kDa were the proteins that antibodies specific for
cow’s milk reacted most pronounced to. Moreover, a hardly visible band was seen between 50 and
75 kDa indicating a weak reactivity towards SA (~66 kDa). There was no visible reaction of antibodies
specific for cow’s milk for camel milk proteins. The opposite situation is shown in Figure 8B where
the specificity of antibodies raised against camel milk was evaluated. Here, antibodies reacted most
pronounced with the camel milk β-casein fraction seen between 25 and 37 kDa standard marker bands,
while there was no detectable reaction towards cow’s milk proteins. However, the pooled serum
dilutions used for the immunoblots were high, with a dilution of 1:3000 for sera raised against
cow’s milk and 1:8000 for sera raised against camel milk, for which reasons only the proteins
with the strongest IgG1 binding capacity were visualised. As the ELISA assay showed very low
cross-reactivity between camel and cow’s milk proteins, we decided to use eight times higher protein
concentration and lower serum pools dilution in order to visualise the proteins responsible for the
cross-reactivity. The dilution used for both camel and cow’s milk raised sera was 1:500. Figure 8C,D
show cross-reactivity between camel and cow’s milk proteins. Antibodies specific for cow’s milk were
able to cross-react exclusively with camel milk whey proteins. There were visible bands between
50 and 75 kDa indicating the most pronounced cross-reactivity with camel milk SA (~66 kDa) and
LF (~75 kDa). Another weak but visible band was detected around 15 kDa indicating a very low
cross-reactivity with camel milk ALA (Figure 8C). Another very weakly detectable band was at
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approximately 150 kDa. This probably corresponded to immunoglobulins [33]. Antibodies specific for
camel milk showed a very weak reaction with cow’s milk caseins between the 25 and 37 kDa standard
marker bands, and with a whey protein appeared between the 50 and 75 kDa standard marker bands
(Figure 8D).Nutrients 2018, 10, x FOR PEER REVIEW  13 of 18 
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4. Discussion
CMA is a major health issue of growing concern, for which reason the World Health Organisation
(WHO) has created a guideline for diagnosis and rationale action [4]. Special hypoallergenic infant
formulas for CMA infants as well as for infants in risk of developing CMA are available. These infant
formulas are based on hydrolysed cow’s milk proteins and designated extensively and partially
hydrolysed infant formulas, respectively, depending on the degree of hydrolysis and peptide size
distribution profile. Additional formulas, based on plants or milk from other mammalians have
also been suggested for CMA infants [8]. However, for example, goat and sheep milk cannot
be recommended for all CMA infants due to the high protein homology and consequently high
cross-reactivity with cow’s milk proteins [2,4,12]. One-humped camel—Camelus dromedaries (Camelidae
family)—has a great evolutionary distance to animals from the Bovidae family [34]. Evolutionary
distance directly influences milk protein composition variances, suggesting great differences between
camel and cow’s milk. Having a different protein composition, camel milk is anticipated to be a
suitable alternative to hypoallergenic cow’s milk-based infant formulas in the near future. To confirm
a role for camel milk in management, primary prevention, and treatment of CMA, a combination of
animal and human studies is needed. Using a BN rat model, we have compared immunogenicity,
allergenicity, and cross-reactivity of camel and cow’s milk proteins.
The present study showed that camel and cow’s milk contain similar immunogenicity as well as
allergenicity, being able to induce comparable levels of specific IgG1 and IgE antibodies with similar
avidity. In addition, the eliciting capacity of the two milk products was shown to be similar. However,
evaluation of the specific antibody reactivity towards cross-reactive proteins was low.
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Whereas antibody responses raised against caseins were dominated by epitopes of the linear type,
antibody responses raised against whey proteins were dominated by conformational epitopes. This is
in line with a previous study showing that while caseins primarily raised antibodies towards linear
epitopes, BLG and ALA primarily induced antibodies towards conformational epitopes, irrespectively
of animals were dosed i.p. or orally [21]. I.p. dosing enables the immune system to recognise proteins
in their native, undigested state. These results correlate very well to the structural folding of the
proteins within the casein and whey fraction of milk, where caseins possess a flexible unstructured
folding [21,35,36], while the predominant proteins within whey, BLG and ALA are globular proteins
containing two and four disulphide bonds, respectively [19,21,37].
Camel and cow’s milk proteins were in general shown to have a very low cross-reactivity.
While approximately only 1 in 30 IgG1 antibodies raised against camel milk could react with cow’s
milk, only approximately 1 in 50 IgG1 antibodies raised against cow’s milk could react with camel
milk. The low cross-reactivity was confirmed by inhibitory ELISA where camel milk could only
inhibit approximately 35% of the response against cow’s milk and cow’s milk could only inhibit
approximately 50% of the response against camel milk. Similar results were observed for the IgE
responses. Low cross-reactivity may reflect differences in the epitope pattern between camel and cow’s
milk proteins directly correlated with a fairly low protein sequence identities.
The present study demonstrates that camel milk may be a suitable alternative to hypoallergenic
infant formulas for CMA infant, as the low cross-reactivity should confer the camel milk low risk of
inducing reactions. This is consistent with human studies showing that the introduction of camel milk
to children with confirmed CMA, who did not respond to the conventional management, had a positive,
rapid and long-lasting effect on their health [20,38]. Other studies have shown that neither camel
milk caseins nor whey proteins could inhibit or bind to sera antibodies from patients with confirmed
CMA [8,39]. In contrast to camel milk, both goat and sheep milk show a large cross-reactivity to cow’s
milk [2,14,40], which is also reflected by the high protein identity, causing a similar epitope pattern.
Human studies also showed that children with confirmed CMA reacted with goat milk due to IgE
antibody cross-reactions [2,15]. In general, goat milk is not recommended for CMA patients without
restrictive supervision of specialists [2,14].
The study showed that cow’s milk was more efficient in inhibiting binding to antibodies raised
against camel milk than camel milk was in inhibiting binding to antibodies raised against cow’s milk.
Certainly, the lack of BLG, one of the major allergenic proteins in cow’s milk [28], may at least partly
explain this difference. This indicates that camel milk in general is a more suitable infant formula for
CMA infant, than is cow’s milk for potential camel milk allergic infants.
The cross-reactivity between camel and cow’s milk caseins was found to be less than the
cross-reactivity between camel and cow’s milk whey proteins, indicating that camel milk would
be a more suitable alternative to hypoallergenic infant formulas for casein allergic infants than for
whey allergic infants. This corresponds very well to the protein identity within the casein fraction
compared to the whey fraction. In addition, immunoblot confirmed that antibodies specific for cow’s
milk were able to exclusively react with camel milk whey proteins, confirming a predominance of
whey proteins cross-reactivity. The reactivity was mostly towards camel milk SA, which is a protein
that is rarely detected to independently cause cow’s milk allergy, and mostly sensitise together with
other milk allergens [41,42].
Small differences were seen between the cross-reactivity accounted for by linear epitopes in
comparison to cross-reactivity accounted for by conformational epitopes, where this study indicated
that there is a tendency to a lower cross-reactivity between conformational epitopes compared to
linear epitopes.
The difference in titre values in each group of immunised rats could reflect weaker antibody
binding due to imperfect matching epitopes or be due to a low a low amount of shared epitopes. It can
be stressed that the second option is the most likely, as the avidity of the cross-reacting antibodies was
equal to the avidity of total population of antibodies.
Nutrients 2018, 10, 1903 15 of 18
Overall, it is suggested that approximately 35–40% sequence identity between allergens is
adequate to induce IgE cross-reactive binding [43]. However, cross-reactions are unusual below
50% identity and mostly requires more than 70% identity [44]. We can therefore conclude that the
low level of cross-reactivity found in the present study is at the expected level for proteins of an
evolutionary distance around 60%. A lower cross-reactivity would probably require an even lower
sequence homology, which again would require milk from an animal with even larger evolutionary
distance to cows. An alternative approach would be to look for milk from animals with a shorter
evolutionary distance to humans.
5. Conclusions
This study showed that, although camel and cow’s milk display similar immunogenicity and
allergenicity, cross-reactivity between their proteins is low. Moreover, selected protein sequence
alignments showed lower protein sequence identity between camel and cow’s milk proteins in
comparison to other mammalian milk proteins such as goat or sheep. With this study, we showed that
camel milk is a promising alternative to hypoallergenic cow’s milk-based infant formulas. For further
evaluation of camel milk and its usefulness as a suitable alternative for hypoallergenic cow’s milk-based
infant formulas in prevention, treatment and management of CMA, studies including oral animal
sensitisation, primary prevention and treatment should be performed. In addition, mechanistic studies,
including in vivo analyses of IgE functionality after oral challenge as well as evaluation of cellular
changes in the gastrointestinal tract, would be of a great importance.
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Abbreviations
ALA α-lactalbumin
BLG β-lactoglobulin
BN Brown Norway
CMA Cow’s milk allergy
DIG dioxigenin
ELISA Enzyme-linked immunosorbent assay
EU endotoxin units
HRP horse-radish peroxidase
IC50 half minimum inhibitory concentration
i.p. intraperitoneally
kDa kilodalton
KSCN potassium thiocyanate
LF actoferrin
LP lactoperoxidase
MW molecular weight
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NA not available
OD optical density
OVA ovalbumin
PBS phosphate buffered saline
PBT-T phosphate buffered saline-tween
PAGE polyacrylamide gel electrophoresis
PVDF polyvinylidene difluoride
RT room temperature
SA serum albumin
SD standard deviation
SDS sodium dodecyl sulphate
TMB 3,3′,5,5′-tetramethylbenzidine
Tris 2-amino-2-(hydroxymethyl)-1,3-propenediol
WHO World Health Organisation
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